A dopaminergic defi ciency in patients with Parkinson's disease (PD) causes abnormalities of movement, behaviour, learning, and emotions. The main motor features (ie, tremor, rigidity, and akinesia) are associated with a defi ciency of dopamine in the posterior putamen and the motor circuit. Hypokinesia and bradykinesia might have a dual anatomo-functional basis: hypokinesia mediated by brainstem mechanisms and bradykinesia by cortical mechanisms. The classic pathophysiological model for PD (ie, hyperactivity in the globus pallidus pars interna and substantia nigra pars reticulata) does not explain rigidity and tremor, which might be caused by changes in primary motor cortex activity. Executive functions (ie, planning and problem solving) are also impaired in early PD, but are usually not clinically noticed. These impairments are associated with dopamine defi ciency in the caudate nucleus and with dysfunction of the associative and other non-motor circuits. Apathy, anxiety, and depression are the main psychiatric manifestations in untreated PD, which might be caused by ventral striatum dopaminergic defi cit and depletion of serotonin and norepinephrine. In this Review we discuss the motor, cognitive, and psychiatric manifestations associated with the dopaminergic defi ciency in the early phase of the parkinsonian state and the diff erent circuits implicated, and we propose distinct mechanisms to explain the wide clinical range of PD symptoms at the time of diagnosis.
Introduction
Parkinson's disease (PD) has typically been considered to be a motor disorder 1, 2 secondary to basal ganglia dysfunction. The defi nition in the 1960s of the nigrostriatal dopaminergic pathway and the discovery of dopamine striatal loss provided one of the best established correlations between clinical features and biochemical pathology. 3 The main manifestations of PD-akinesia or bradykinesia, rigidity, and tremor-are now known to be directly related to dopaminergic striatal loss. Other clinical manifestations, albeit usually less noticeable, that are also seen at the time of diagnosis include sensory symptoms (eg, pain and tingling), hyposmia, sleep alterations, depression and anxiety, and abnormal executive, working memory-related functions.
The clinical manifestations of PD after diagnosis comprise a mixture of disease-related and treatmentinduced manifestations. Motor and non-motor side-eff ects directly related to treatment such as dyskinesias or hallucinations, and other features arising after long-term disease progression (eg, gait problems and disequilibrium, autonomic failure, and dementia), are not covered in this Review. We discuss the pathophysiological mechanisms underlying the main clinical features of PD at the time of diagnosis and, therefore, when the clinical features are mainly aff ected by catecholaminergic (ie, mainly dopaminergic) defi cits. We provide a diff erential explanation for the anatomo-functional basis of the major clinical manifestations of PD (ie, tremor, rigidity, akinesia, dysexecutive syndrome, and depression) to expand the views and concepts held by the classic pathophysiological model.
Key motor features: basic concepts
PD motor manifestations begin focally, typically in one limb segment, when dopamine concentrations fall below 60-70% in the contralateral striatum. The onset of motor features correlates with loss of dopamine in the posterior putamen (fi gure 1), corresponding to the motor region of the striatum. The main features of PD (ie, akinesia or bradykinesia, rigidity, and tremor) are therefore mainly related to dysfunction of the motor circuit (fi gure 2).
Reduced and slow movements
The term akinesia (strictly defi ned as "lack of movement") comprises many clinical features, which need to be diff erentiated for the discussion of underlying patho physiological mechanisms. One type of akinesia, hypokinesia, consists of reduced frequency and amplitude of spontaneous movement, which is particularly noticeable in automatic movements. Typical manifest ations are reduced blinking rate and facial expressions, absent or reduced arm swinging, and absence of associated movements during daily life activities such as rising from a chair and waving. All these hypokinetic features were collectively grouped under the descriptive term "poverty of movement" by Wilson 1 in his infl uential series on disorders of motility and tone. This term also included a tendency of patients to stand still and to have reduced gesticulation. The parkinsonian gait includes several hypokinetic features such as reduced stride length and decreased off -ground elevation of the feet, leading to short stepping and shuffl ing, which are associated with reduced arm swinging and predominance of fl exor posture. Micrographia is a particular form of hypokinesia, in which a highly learned automatic motor task is not only characteristically reduced in amplitude but is also associated with slowness in the execution.
Bradykinesia is characterised by reduced speed when initiating and executing a single movement and progressive reduction of its amplitude, up to complete cessation 1, 2 during repetitive simple movements.
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Undertaking sequential or simultaneous movements is severely disrupted and frequently impeded, which has substantial eff ects on daily living. 5 Kinematic studies have consistently shown that both movement time for single movements and inter-onset latency for sequential movements are increased. Although all types of movements are slower in PD, there is some evidence that externally triggered movements are less impaired than those that are self-initiated; this is best exemplifi ed by gait improvement when external cues are provided. 6 
Disorders of muscle tone
Rigidity is characterised by increased muscular tone to palpation at rest, reduced distension to passive movement, increased resistance to stretching, and facilitation of the shortening reaction. Both fl exor and extensor muscular groups are involved but fl exor muscles of the limbs are more aff ected in the early stages of disease progression. 7 Increased resistance is dependent on velocity and is more noticeable when the examined joint is stretched slowly; 7 fast displacement is associated with minimum or no rigidity. Joint elongation is typically increased by voluntary activation of other body parts (Froment's manoeuvre) and is commonly interrupted by so-called cog-wheel rigidity.
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Tremor
Tremor is typically characterised by 4-6 Hz activity at rest in the limbs with distal predominance. The fi ngers are most commonly aff ected, giving rise to the classic "pill-rolling" tremor. The jaw muscles and tongue can occasionally be involved but axial muscles (abdomen, back, and hip) and the neck are rarely aff ected. Tremor increases in amplitude, or can be triggered by manoeuvres such as voluntary movement of other body parts, arithmetic calculation, and stress. Levodopa and other dopaminergic drugs are less effi cacious against The motor circuit and its somatotopic organisation The motor circuit (indicated by red arrows connecting the regions that modulate leg movements) is somatotopically organised throughout the loop, with the regions representing leg movements lying dorsal and medial, those representing face movements lying ventral and lateral, and those representing arm movements lying in-between. The somatotopic arrangement of the primary motor cortex is generally maintained in the striatopallidal and subthalamic nuclei. Figure reprinted from Obeso and colleagues. 4 GPe=globus pallidus pars externa. GPi=globus pallidus pars interna. STN=subthalamic nucleus.
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tremor than other key features of PD, an assumption generally accepted without clear explanation or formal assessment.
Pathophysiology of key motor features: the classic model
The classic pathophysiological model of the basal ganglia, which was elaborated in the 1980s, 9-11 triggered a large amount of experimental and clinical activity and led to the revitalisation of surgery for PD and other movement disorders. Figure 3 provides a summary of this original model in the healthy and pathological states, and the table summarises the main experimental fi ndings that support this model. The initial model, based on cortico-basal ganglia-cortical loops and changes in neuronal fi ring rate in the globus pallidus pars interna (GPi) and the substantia nigra pars reticulata (SNr), is now recognised as limited and incapable of providing explanations for many clinical observations. The main clinical paradoxes of this model 13, 14 are summarised in the panel.
However, there are several aspects that fi t well with this model. The importance of hyperactivity of the subthalamic nucleus (STN) and GPi in the parkinsonian state has been substantiated by diff erent functional approaches in patients with PD. An increased neuronal fi ring rate in the "off " state is a typical fi nding in the STN, 15 which correlates with increased metabolic activation measured by PET of the putamen and the GPi. 16 Moreover, substantial amelioration of motor features and improvement of neurophysiological and PET metabolic markers have been documented after surgery (ie, pallidotomy, subthalamotomy, and deep brain stimulation).
17,18
Pathophysiology of PD: expanding classic concepts
The basal ganglia networks are now known to be anatomically and physiologically subdivided into motor, oculomotor, associative, and limbic territories that are involved in functions such as learning, planning, working memory, and emotions 19, 20 (fi gure 4). The dopaminergic system innervates all striatal regions, as well as other non-striatal basal ganglia nuclei and limbic and associative cortical areas. 21 Progressive loss of dopaminergic striatal innervation (fi gure 1) is associated with the emergence of executive dysfunction, learning problems, and mood disorders. 22, 23 Loss of dopaminergic cortical input is also an early feature, 24 and cell loss in the raphe nuclei and locus coeruleus 25 might also have a role in the origin of non-motor manifestations. In this section we discuss the origin of the main movement, cognitive, and psychiatric manifestations commonly seen in early (ie, around diagnosis) phases of PD.
Motor features Akinesia
Diffi culty with movement has been generally considered the main manifestation of dysfunction of the basal ganglia. 1, 2 The clinical characteristics of akinesia indicate that hypokinesia and bradykinesia are probably mediated by diff erent pathophysiological mechanisms. Hypokinesia is closely associated with reduced rhythmic movements, which in turn depends on timing mechanisms. This timing is mediated by central pattern generators, which are neuronal circuits that fi re synchronously without sensory input to produce rhythmic activity. Central pattern generators thus provide a pacemaker function to the nervous system. These generators are well typifi ed in the spinal cord for locomotion in quadruped animals and in the brainstem for the respiratory centre. 26 Presumably, other highly rhythmic and automatic movements such as eye blinking and arm swinging also have a central pattern generator, although the precise anatomical basis is undefi ned.
Dopamine and other catecholamines have a fundamental role in modulating the excitability of the central pattern generator and the perception of time. 27 Additionally, the substantia nigra and the basal ganglia connections with the supplementary motor area and the lateral premotor and dorsolateral prefrontal cortices are involved in time processing in animals and human beings. 28, 29 Moreover, time estimation and rhythm Cortical motor areas project glutamatergic axons to the putamen, which sends GABAergic projections to the GPi and the SNr by two pathways: the monosynaptic GABAergic "direct circuit"(putamen-GPi) and the trisynaptic (putamen-GPe-STN-GPi/SNr) "indirect circuit". Dopamine from the SNc facilitates putaminal neurons in the direct pathway and inhibits those in the indirect pathway. Activation of the direct pathway leads to reduced neuronal fi ring in the GPi/SNr and movement facilitation, while activation of the indirect pathway suppresses movements. The STN is also activated by an excitatory projection from the cortex ("hyperdirect" pathway), a connection that was not included in the original model. In Parkinson's disease (B), dopamine defi cit leads to increased activity in the indirect circuit, in which STN hyperactivity is a key characteristic, and hypoactivity in the direct circuit. Together, these actions result in increased GPi/SNr output inhibition of the VL nucleus of the thalamus and reduced activation of cortical and brainstem motor regions. In the dyskinetic state (C), abnormal putaminal dopaminergic activation (L-dopa arrow) leads to hypoactivity in the indirect circuit and hyperactivity in the direct circuit, resulting in reduced inhibitory output activity from the basal ganglia. Green arrows indicate excitatory activity and red arrows indicate inhibitory activity. Figure modifi ed from Obeso and colleagues. 12 GPe=globus pallidus pars externa. GPi=globus pallidus pars interna. SNc=substantia nigra pars compacta. SNr=substantia nigra pars reticulata. STN=subthalamic nucleus. VL=ventrolateral nucleus.
Review generation are abnormal in PD 27, 30 and increased striatal expression of D2 receptors in rodents (PD model; table), is associated with impaired interval timing. 31 Extracellular neuronal recordings in non-human primate and rodent models of PD have also shown impairment in temporal processing of spatial information. 32 Therefore, hypokinesia in PD is probably mediated by disruption of central pattern generators and abnormal timing mechanisms. GPi and SNr project and activate several brainstem regions (ie, the pedunculopontine nucleus and the superior colliculus) that are functionally impaired in the parkinsonian state. The clinical features of hypokinesia suggest that excessive inhibition of brainstem circuits from the basal ganglia might have a major role in its pathophysiology. For example, a low blinking rate suggests direct inhibition of the central pattern generators, whereas increased excitability of the blink refl ex and Meyerson's sign might be caused by SNr overinhibition of the superior colliculus and secondary disinhibition of the nucleus gigantocellularis. 33 Brainstem mechanisms are also likely to be engaged in the origin of postural disturbances and other motor signs such as dysphagia and dysarthria; however, these features typically occur later in the disease.
Bradykinesia can be understood as a failure of neuronal recruitment or "energisation". 34, 35 Movement patterns are correctly selected but the parameters for undertaking the action in terms of speed and amplitude of the movement are incorrectly set, 36, 37 despite preserved capability to choose the appropriate parameters. 35 Striatal medium spiny neurons receive many glutamatergic aff erents (about 10 000 synaptic contacts per medium spiny neuron) and about 100 of these neurons converge into one GPi neuron. 38 This large input to output gradient requires that the basal ganglia is largely involved in selecting which neuronal signals are facilitated or not. 39, 40 In the parkinsonian state, activity in the motor circuit is disrupted at several fundamental levels. First, the proportion of striatal medium spiny neurons and GPi neurons responding to stimulation is increased and the inhibition to excitation ratio decreases substantially. 41 Second, selectivity of somatotopic neuronal responses to peripheral stimulation is blurred in cortical motor areas 42, 43 and basal ganglia nuclei. 44 Third, corticostriatal activity is biased towards activation of striatal neurons in the indirect circuit, 45 which, in association with increased collateral inhibition from medium spiny neurons, 46 leads to globus pallidus pars externa (GPe) inhibition 
Pallidotomy abolishes dyskinesias
Levodopa-induced dyskinesias in patients with Parkinson's disease are eliminated by GPi lesions, which is incompatible with a model that associates excessive inhibition with the GPi/SNr and reduced basal ganglia eff erent activity with dyskinesias.
No defi cits after interrupting basal ganglia-cortical connections
Disruption of the motor circuit by surgical lesions (ie, thalamotomy or pallidotomy) does not aggravate bradykinesia in Parkinson's disease nor induces any new motor defi cit.
GPi=globus pallidus pars interna. SNr=substantia nigra pars reticulata. STN=subthalamic nucleus.
Putamen
GPe GPi STN SNr
Parkinsonian state
• Increased expression of D2 receptors, enkephalin, preproenkephalin (rat, monkey)
• Decreased expression of D1 receptors, dynorphin, preprotachykinin and substance P (rat, monkey)
Decreased rate of neuronal fi ring (rat, monkey)
• Increased rate of neuronal fi ring (monkey, patients with PD)
• Increased expression of CO-I and GAD (rat, monkey)
• STN lesion reduces CO-I and GAD (monkey) and neuronal fi ring rate (monkey, rat)
• Increased rate of neuronal fi ring (rat, monkey, patients with PD)
• Increased expression of CO-I (rat, monkey)
• Decreased expression of 2-DG (monkey)
• STN lesion improves parkinsonism (monkey, rat, patients with PD)
• Increased expression of CO-I and GAD (monkey, rat)
• STN lesion reduces expression of CO-I and GAD (monkey)
Treatment with L-dopa or apomorphine
• Normalisation of expression of D1 and D2 receptor (rat, monkey)
• Normalisation of expression of preprotachykinin and substance P (rat, monkey)
Normalisation of rate of neuronal fi ring (monkey)
• Decreased rate of neuronal fi ring (rat, monkey, patients with PD)
• Decreased expression of CO-I and GAD (rat, monkey)
• Decreased expression of CO-I (monkey)
• Decreased expression of CO-I and GAD (monkey)
2-DG=2-deoxyglucose measured by autoradiography. 6-OHDA=6-hydroxydopamine. CO-I=cytochrome oxidase-I measured by in situ hybridisation. GAD=glutamic acid decarboxylase measured by in situ hybridisation. GPe=globus pallidus pars externa. GPi=globus pallidus pars interna. MPTP=1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. PD=Parkinson's disease. SNr=substantia nigra pars reticulata. STN=subthalamic nucleus.
Table:
Summary of the main fi ndings in the 6-OHDA rat and the MPTP monkey models of parkinsonism and in patients with PD Review and increased STN and GPi output (fi gure 3B). Fourth, striatal plasticity is impaired, so that synaptic changes induced by cortical aff erent stimulation such as long-term depression or potentiation are eliminated. 47 Fifth, neuronal fi ring synchrony increases substantially within basal ganglia structures such as the STN and GPi 43, 48 and also among diff erent structures throughout the motor loop nuclei, 49, 50 producing abnormal oscillatory activity. In patients with PD, 51 the "off " medication state is characterised by a net predominance of beta-band activity in the STN, which is substantially reduced in the "on" state 52 (fi gure 5). This activity propagates to the basal ganglia and thalamocortical projection, so that the entire motor circuit is synchronised at about 20 Hz. 50 Accordingly, bradykinesia can be seen as a defect of the motor circuit to generate a phasic and time-locked inhibition of GPi neurons and to achieve substantial desynchronisation in the beta band to facilitate recruitment of cortical motoneurons appropriately adjusted for the intended movement. 41, [53] [54] [55] This activity is not only due to reduced activation of medium spiny neurons in the direct circuit, 56 but also to the combination of functionally hypoactive GPe with hyperactive STN and GPi, which reduces the probability that a cortical signal will be facilitated via the STN-GPe-GPi loop. 56, 57 Increased responsiveness of the STN-GPi might also increase movement-related activity through the hyperdirect pathway and contributes to progressive attenuation of repetitive and sequential movements and micrographia. A similar explanation might account for the prolonged latency between sequential time-locked simple movements that are automatically undertaken (ie, shaking hands or saluting at a distance). When the sequence involves diff erent movements and body parts, there is a higher demand on serial striatal input-output and GPe-STN-GPi modulation, accounting for the greater slowness and increased errors in execution compared with single (one joint) movements.
Rigidity
The clinical features of rigidity suggest a complex pathophysiological origin for this key feature. Thus, increased muscle tone at rest and augmented resistance to passive displacement of the joint readily evoke diff erent mechanisms. On the one hand, there must be facilitation of spinal cord motoneuron activity, probably related to increased supraspinal driving or facilitation. On the other hand, a fundamental role for the stretch refl ex must be considered. Classic physiological studies have shown that rigidity is abolished by dorsal root sectioning or by local dural injection of anaesthetics supporting a refl exive origin. 58 The latter fi nding led to many studies of spinal cord excitability in the 1960s and 1970s. These studies showed that spinal motoneuron responsiveness to aff erents from muscle spindles (type Ia fi bres), which sustains the clinically applied tendon jerk, is unaltered in PD but the inhibition normally evoked from tendon organs (type Ib fi bres) is reduced, 59 whereas interneurons activated by secondary muscle aff erents (type II fi bres) are hyperactive. These fi ndings suggest a shifting of spinal cord motoneurons towards increased activity in response to peripheral stimulation.
The importance of supraspinal mechanisms in rigidity has also received much attention. Slow and sustained muscle stretching (giving rise to the tonic stretch refl ex) is increased in patients with PD. 7 Furthermore, brief and rapid phasic muscle stretching of the limbs evokes a typical spinal refl ex (latency about 20 ms) and a long-latency response (about 40 ms). The long-latency stretch refl ex is mediated through the primary motor cortex and is increased in patients with PD. However, this stretch refl ex is larger in distal muscles than in proximal muscles of the upper limb, whereas rigidity is also present proximally and in the axial musculature. The correlation of this refl ex with clinical rigidity is not clear. 60 The importance of cortical mechanisms is reinforced by fi ndings of increased primary motor cortex excitability as detected by magnetic cortical stimulation. 61, 62 Stimulation of the premotor cortex in patients with PD in the "off " medication state did not increase motor cortex excitability, an eff ect that was present in healthy controls and in the same patients with PD when "on" medication. 63 These results are similar to fi ndings in monkeys treated with MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in which primary motor cortex neurons responded more vigorously and with less specifi city to passive limb movements, although the fi ring rate at rest was not modifi ed. 
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Surgery of the basal ganglia and motor thalamus has a clear antirigidity eff ect, indicating a direct role of the motor circuit in the origin of rigidity. How dopamine defi ciency and increased basal ganglia output activity are associated with primary motor cortex excitability and rigidity is not understood. There might be several possible and not mutually exclusive mechanisms. For example, changes in GABA and cholinergic interneurons lead to reduce intrastriatal inhibition in the indirect circuit, which could facilitate responses to peripheral stimulation. Neuronal responsiveness of the STN and GPi to peripheral stimulation is increased in the parkinsonian state, suggesting that responses to normal muscle aff erent impulses could facilitate cortically mediated responses. Hyperactivity of area 4 (the primary motor cortex) plus increased gain in the cortico-STN-GPi microcircuit and the loss of somatotopic specifi city could explain Froment's sign. However, neuronal discharges in the STN and GPi should lead to cortical inhibition or absence of facilitation, which does not explain the excessive response to stretching that characterises rigidity and the increased muscle tone at rest. Thus, rigidity is not explained by the classic model of basal ganglia pathophysiology. The origin of rigidity in PD would be easier to understand if basal ganglia output to the thalamus was not only inhibitory. Additionally, rigidity probably involves disinhibition of brainstem mechanisms (ie, reticulospinal projections 64 mediating muscle tone and posture).
Tremor
Rhythmic and synchronous neuronal fi ring recorded in the STN and the GPi correlates with tremor in the limbs in both monkeys treated with MPTP and in patients with PD. 65 Surgery of the STN can readily stop parkinsonian tremor. This tremor is inhibited at the onset of a voluntary muscle contraction involving the same body part and by cortical magnetic stimulation, and disappears after stroke causing hemiparaesis, all of which indicate that the pyramidal tract is the fi nal output pathway mediating tremor. However, rhythmic fi ring is better recorded and tremor stopped in the ventralis intermedius nucleus (Vim) of the thalamus. 66 The Vim is outside the basal ganglia projection territory; it receives propioceptive (type Ia) aff erents from muscle spindles and projects to the primary somatosensory cortex and motor cortex (area 3a). In monkeys treated with MPTP, 5 Hz stimulation of the GPi is not capable of recruiting and driving motor cortex activity, revealing a fi ltering characteristic of low frequency activity in the motor circuit. 67 This fi nding means that rhythmic activity in the basal ganglia is unlikely to drive cortical-spinal motor activity to generate tremor. The origin of tremor in PD is therefore a pathophysiological puzzle. Specifi cally, the mechanistic link between dopamine defi ciency and abnormal oscillatory activity in an extensive motor network that involves the basal ganglia, the cerebellar, the thalamus and the motor cortex needs to be understood. We suggest two main possible mechanisms.
First, basal ganglia could be directly involved. In this potential mechanism, increased basal ganglia output leads to increased excitability of the primary motor cortex and increased sensitivity to stretching and synchronous basal ganglia fi ring, thus facilitating the onset of oscillations around the motor loop. Muscle stretching evokes neuronal responses in the STN of patients with PD, which show a pronounced tendency to oscillate at tremor frequency. The latency of about 60-100 ms of Review these responses and total movement time of each tremor beat of 150-200 ms fi t with a loop through the basal ganglia at 5 Hz. Loss of direct dopaminergic control of the microcircuity network formed by the STN-GPe/GPi interconnections could play a part in this regard. 68 Second, the neuronal network underlying tremor might not primarily lie in the basal ganglia. This possibility is supported by the high association between the Vim and cerebellar activation and tremor and by the exquisite sensitivity of Vim manipulations to cessation of tremor. Dopaminergic projections to the thalamus are known to be present in monkeys and human beings, 69 and the STN-GPi form a loop with the centromedian thalamic nuclei, 70 which in turn is reciprocally connected to the primary motor cortex. Extrastriatal dopamine denervation, or loss of other transmitters, could facilitate synchronous 5 Hz activity within the thalamus and basal ganglia. The possibility therefore arises that loss of catecholaminergic neurons required for tremor in PD might have a diff erent pattern to that underlying the akinetic-rigid presentation. ¹⁸F-fl uorodopa PET striatal uptake does not correlate with tremor severity 71 and resting tremor is not associated with striatal lesions. However, a specifi c pattern of neurodegeneration accounting for tremor and diff erentiating predominant tremor from akinetic-rigid forms of PD has not been yet found. 72 
Key motor features of PD: conclusions and suggestions
Two main characteristics of parkinsonian motor features are the greater diffi culty in moving with self-initiated than with externally triggered movements and the abnormal activation of specifi c body parts. Movements of the limbs or gait improve when initiated in response to external cues, and bradykinesia is made worse when more than one body part is activated simultaneously; both rigidity and tremor are also increased or are induced by movements of other body parts. These features fi t well with the concept that the basal ganglia have a fundamental role in modulating activity of premotor areas (supplementary motor area, pre-supplementary motor area, and dorsolateral prefrontal cortex) that deal with selection of self-initiated actions. 39, 40, 55 However, analysis of the main motor manifestations of PD suggests a more complex pathophysiological origin. Thus, key features of hypokinesia such as absence of spontaneous movement or reduced blink rate are unlikely to share mechanisms with bradykinetic manifestations such as reduced amplitude and slowness of the limbs or simultaneous manual movements. We suggest that hypokinesia is related to overinhibition of the brainstem central pattern generator, whereas bradykinesia is related to perturbed activation or inhibition of the basal ganglia-thalamocortical pathway. The primary motor cortex is impaired in a complex way in the parkinsonian state and there is a functional uncoupling of premotor areas and primary motor area. This impairment could be due to a preferential involvement of area 4 activity in the origin of rigidity (and possibly tremor), whereas hypoactivation of premotor areas could underlie bradykinesia. Recent data indicate that bradykinesia itself encompasses several mechanisms, with amplitude and speed of movement probably mediated by diff erent mechanisms, 37 which suggest diff erential involvement of cortical motor areas. Additionally, the role of basal ganglia output on to the brainstem deserves greater attention. Several features of akinesia and rigidity probably involve a brainstem mechanism. It is diffi cult to explain the key motor features of PD on the basis of a common pathophysiological mechanism. Moreover, current data on the anatomo-functional organisation of the basal ganglia can not comprehensively explain the range of motor manifestations associated with dopamine depletion in PD.
Cognitive manifestations
Cognitive defi cits in PD range from "frontal" executive dysfunction, which can be present in a mild form from early stages, to frank dementia in late stages. Here, we concentrate on disorders of executive function, which can be recognised as early features of PD.
Executive dysfunction
Executive function refers to processes involved in the higher-order control of behaviour, such as strategic planning and problem solving, maintaining and shifting attention, and behavioural regulation: the ability to initiate, execute, inhibit, and monitor a sequence of actions. Depending on sample characteristics and criteria used, cognitive defi cits are present in early PD in 20-40% of patients [73] [74] [75] but are often overshadowed by motor features.
The fi nding that patients with PD show defi cits compared with matched controls on several standardised neuropsychological tests of executive function such as the Wisconsin card sorting test, verbal fl uency, and the Stroop test has been well documented. 76 Patients with PD also show impaired performance on other tests of executive function that require planning and problem solving 76, 77 or shifting of attentional set, 77, 78 on tasks requiring suppression of prepotent or habitual responses, 76, 79 and in task situations that require sharing of attentional resources for concurrent performance of two tasks. 80, 81 Such impairment becomes more evident when patients have to rely on internal control of attention relative to when external cues are available to guide behaviour, 82 in a way that is similar to what occurs with movement. Other defi cits of cognitive function, such as impairment of visuospatial function, can also occur in PD, 83 but language is generally intact in early PD. [73] [74] [75] Memory impairment in early PD could be largely due to eff ortful retrieval, as cueing improves recall and recognition memory is usually not impaired, 76 ,84 although defi cits in recognition memory have been found in other Review studies (reviewed elsewhere 85 ). Patients with PD have impaired implicit learning on both cognitive and motor tasks, such as the weather prediction task 86 and the serial reaction time task. 87 Generally, many aspects of the dysexecutive syndrome improve with dopaminergic treatment. 88, 89 However, dopaminergic medication has a detrimental eff ect on other aspects of cognition, such as reversal or conditional associative learning. These defi cits have been attributed to a dopamine overdose eff ect in the frontostriatal circuits through the ventral striatum (orbitofrontal, anterior cingulate, and inferotemporal circuits). This eff ect could be because there is not substantial dopamine depletion in these circuits in the early stages of PD.
90,91
Pathophysiology of executive dysfunction
Reduced ¹⁸F-fl uorodopa uptake in the caudate has been associated with executive dysfunction in patients with PD in some 92, 93 but not all studies, 94 thus implicating nigrostriatal dopamine depletion in these cognitive defi cits. The mesocortical dopamine system is also aff ected, 95 although prefrontal overactivity, particularly in the anterior cingulate, has been found at early stages of the disease. 96 Imaging studies have shown that executive defi cits and working memory impairment in patients with PD are associated with dysfunction in the basal ganglia, 23, 79, 97, 98 the dorsolateral prefrontal cortex, 79, 99 or the caudate and prefrontal cortex, 100 thus implicating both the nigrostriatal and the mesocortical pathways in these defi cits. However, a recent ¹¹C-raclopride study of spatial working memory concluded that executive dysfunction in patients with early PD is associated with impaired nigrostriatal function and that mesocortical dopaminergic function is well preserved in early PD. 22 Similarly, data from several studies in monkeys with minimum motor defi cits after low and slow MPTP exposure have shown defi cits in executive function and attention, 101 which were best explained by a nigrostriatal lesion. 102 These fi ndings suggest that dysfunction of cortico-basal ganglia associative areas secondary to dopamine depletion might have an important role in early executive problems in patients with PD. However, the relative contribution of the nigrostriatal and mesocortical dopamine depletion to executive dysfunction probably varies during the course of the illness and also depends on the nature of the specifi c executive process under investigation. Evidence also implicates other neurotransmitters such as acetylcholine in the cognitive manifestations of PD.
88,103-105
Psychiatric manifestations
A premorbid personality has been described in several studies. 106, 107 The typical personality of patients with PD is mainly characterised by emotional and attitudinal infl exibility, introversion, and a depressive tendency, which can precede the development of motor abnormalities by many years.
Psychiatric symptoms might appear at any time, usually worsen as the disease progresses, and occur frequently in patients with PD but without dementia. 108 Depression, anxiety, and apathy are the most prevalent symptoms. Apart from these features, most psychiatric symptoms that develop in the course of PD are seen in patients with advanced PD and are associated with complications derived from chronic dopaminergic treatments. 109 
Psychiatric problems in patients with early PD
In untreated patients with early PD, depression (37%), apathy (27%), sleep disturbances (18%), and anxiety (17%) are the most common neuropsychiatric symptoms. 110 Patients with PD who have never been treated also have deficits on reward processing and novelty seeking, which can be reversed by dopamine agonist therapy. 106, 111 Longitudinal studies assessing the predominant clinical psychiatric manifestations during disease progression are scarce. 112 Depression occurs in about 40-50% of patients with PD throughout the course of the disease, 113 but this symptom is commonly underdiagnosed and undertreated, despite being a predictor of poor quality of life. 114 Guilt and self-blame are less frequently reported. Suicidal ideation is not uncommon, but suicidal behaviour is rare. Depression is manifested as pessimism and feelings of hopelessness, can be associated with apathy and anxiety, and can occasionally be diffi cult to discern from symptoms such as bradyphrenia, fatigue, and sleep disturbances. Apathy is a generalised lack of motivation accounting for a decrease in goal-orientated activities, loss of interest, and blunted emotional experience. Apathy is seen in 17-70% of patients with PD, 115, 116 and frequently coexists with depression or dementia, although it can occur as the sole major manifestation 116 or can be associated with executive dysfunction. 117 Generalised anxiety, panic attacks, and social phobias are common in PD. 118 About 40% of patients have anxiety, 119, 120 although a recent series reported a prevalence of 69% (930 of 1351). 108 The symptoms include apprehensiveness, nervousness, irritability, and feelings of impending disaster as well as palpitations, hyperventilation, and insomnia. Panic disorder is the most common anxiety disorder in PD.
Pathophysiological basis of psychiatric manifestations
The pathophysiological basis of the non-drug-induced psychiatric manifestations in PD is poorly understood. Depression and apathy have been linked to ventral striatum and mesolimbic dopaminergic denervation. 121, 122 Involvement of norepinephrinergic 122 and serotoninergic metabolism has also been suspected. 123 As apathy, anxiety, and depression precede disease onset in 30% of recently diagnosed patients, 124 and there is no evidence of generalised catecholaminergic cell loss in patients with early PD, these manifestations could be associated Review with dopaminergic striatal defi cit. Thus, dopaminergic treatments are usually benefi cial 125 and lead to a period of restored behaviour and mood. However, the available data do not allow any fi rm conclusion regarding the relative role of catecholamines in the origin of depression and other early psychiatric manifestations. In patients with more advanced disease, depression, acute sadness, or dysphoria might be associated with "off -drug" fl uctuations, 126 which could be seen as the opposite of the hyperdopaminergic behaviours (ie, impulse control disorders 109 ) induced by dopaminergic drugs. Additionally, apathy improves with dopaminergic treatment.
127
Conclusions
The basal ganglia networks involve complex sets of cortical and subcortical connections involved in motor control, cognitive functions, and emotional processing, probably through a common pathway, whereas the nigrostriatal dopaminergic system modulates input and the glutamatergic subthalamic projection regulates output. The wide clinical range of symptoms in patients with PD, even in early stages, could be due to dysfunction in distinct cortico-basal ganglia loops. The classic pathophysiological model of the basal ganglia does not explain the origin of rigidity and tremor or the constellation of features comprising akinesia. Moreover, there is insuffi cient understanding of the mechanisms underlying executive dysfunction and psychiatric features. The eff ect of defi cits in neurotransmitters other than dopamine, albeit known for many years, has not been adequately incorporated in the pathophysiology of PD. What is now required is a new holistic model dealing with the broadened clinical manifestations in early and later stages. The role of compensatory mechanisms would be an important feature to consider and incorporate into future models.
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